Colchicine for Acute Gout
Recommended Treatment Regimen
For acute gout, use low-dose colchicine (1.2 mg at first sign of flare, followed by 0.6 mg one hour later) as first-line therapy alongside NSAIDs or corticosteroids, with mandatory dose adjustments for renal impairment and absolute avoidance in patients with severe renal disease (CrCl <30 mL/min) who are taking CYP3A4 or P-glycoprotein inhibitors. 1, 2
First-Line Treatment Options
The American College of Physicians recommends choosing between three equally effective options for acute gout: 1
- Corticosteroids (prednisolone 35 mg daily for 5 days)
- NSAIDs (any potent NSAID at full dose)
- Colchicine (low-dose regimen)
Corticosteroids should be considered first-line in patients without contraindications because they are safer and lower cost than alternatives. 1
Optimal Colchicine Dosing
For Acute Gout Flares
The recommended regimen is 1.2 mg at the first sign of flare, followed by 0.6 mg one hour later (total 1.8 mg over one hour), then continue 0.6 mg once or twice daily until the attack resolves. 1, 2, 3, 4
This low-dose regimen is as effective as the older high-dose regimen (4.8 mg over 6 hours) but with significantly fewer gastrointestinal adverse effects—the low-dose group had an adverse event profile similar to placebo, while 76.9% of high-dose patients experienced diarrhea. 1, 4
Critical Timing Window
Treatment must be initiated within 36 hours of symptom onset for colchicine to be effective, with maximum benefit when started within 12 hours. 1, 2, 5
Renal Impairment Adjustments
Mild to Moderate Renal Impairment (CrCl 30-80 mL/min)
- No dose adjustment required for acute treatment, but monitor closely for adverse effects. 3
- For prophylaxis, no adjustment needed but close monitoring is essential. 3
Severe Renal Impairment (CrCl <30 mL/min)
- For acute treatment: Give single dose of 0.6 mg only, do not repeat for at least 2 weeks. 5, 3
- For prophylaxis: Start with 0.3 mg daily, increase cautiously with monitoring. 5, 3
Dialysis Patients
- For acute treatment: Single dose of 0.6 mg, do not repeat for at least 2 weeks. 5, 3
- For prophylaxis: 0.3 mg twice weekly with close monitoring. 3
Absolute Contraindications
Do NOT prescribe colchicine to patients with renal OR hepatic impairment who are taking: 1, 2, 6, 3
- Strong CYP3A4 inhibitors (clarithromycin, erythromycin, ketoconazole, ritonavir)
- P-glycoprotein inhibitors (cyclosporine, ranolazine)
Fatal colchicine toxicity has been reported with these combinations. 6
Gastrointestinal Issues Management
The low-dose colchicine regimen (1.8 mg total) has a gastrointestinal adverse event rate similar to placebo (23% diarrhea vs. 77% with high-dose). 4
If gastrointestinal issues occur or are anticipated:
- Switch to corticosteroids (prednisone 30-35 mg daily for 3-5 days, then stop or taper over 7-10 days) 1, 2
- Use intra-articular corticosteroid injection for monoarticular gout 1, 2
- Avoid NSAIDs if patient has history of gastrointestinal bleeding, ulcers, or is on anticoagulants 1
Alternative Treatment Options When Colchicine is Contraindicated
First-Line Alternatives
NSAIDs at full FDA-approved doses until complete resolution: 1, 2
- Naproxen 500 mg twice daily
- Indomethacin 50 mg three times daily
- Sulindac at approved dosing
However, NSAIDs are contraindicated in patients with: 1
- Renal disease
- Heart failure
- Cirrhosis
- Recent gastrointestinal bleeding
Second-Line Alternatives
- Prednisone 0.5 mg/kg/day (or 30-35 mg daily) for 5-10 days, then stop or taper over 7-10 days
- Methylprednisolone dose pack
Intra-articular corticosteroids (dose varies by joint size) for monoarticular gout 1, 2
Intramuscular triamcinolone acetonide 60 mg followed by oral prednisone 1
Combination Therapy for Severe Attacks
For severe acute gout with multiple large joints or polyarticular arthritis, initial combination therapy with colchicine and NSAIDs is appropriate. 1, 2
Acceptable combinations include: 1
- Colchicine + NSAIDs
- Oral corticosteroids + colchicine
- Intra-articular steroids with any other modality
Avoid combining NSAIDs with systemic corticosteroids due to synergistic gastrointestinal toxicity. 1, 2
Common Pitfalls to Avoid
- Never use the obsolete high-dose regimen (0.5 mg every 2 hours until relief or toxicity)—this causes severe diarrhea in most patients with no additional benefit 2
- Never repeat colchicine treatment courses more frequently than every 2 weeks in patients with severe renal impairment 3
- Never initiate colchicine for acute flare in patients already on prophylactic colchicine who are taking CYP3A4 inhibitors 3
- Never delay treatment beyond 36 hours—effectiveness drops significantly after this window 1, 2, 5
- Monitor for neuromuscular toxicity and myopathy in patients with renal impairment taking colchicine prophylaxis, especially when co-prescribed with statins 6
Hepatic Impairment Considerations
Mild to Moderate Hepatic Impairment
No dose adjustment required for acute treatment, but monitor closely for adverse effects. 3
Severe Hepatic Impairment
For acute treatment: No dose adjustment needed, but do not repeat treatment course more than once every 2 weeks. 3
For prophylaxis: Consider dose reduction with careful monitoring. 3